Pay in 4 interest-free payments of $5.11 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Retatrutide for type 2 diabetes: Phase 2 trial results (36-week study, HbA1c reductions, weight loss) New England Journal of Medicine (2023) Jastreboff AM, et al
Czechia Greater than 99.8 % purity confirmed by COA Assay content verified at 55.1 mg Endotoxin level below 0.001 EU/mg No detectable heavy metals or microbial contamination NNMT-related research compound for controlled laboratory studies For research use only not for human or veterinary use For laboratory research only
How much bacteriostatic water are you adding
The volume depends on both the mg content of your vial and your target concentration
Expected timeline: Week 1 to 2: Initial reduction in inflammation and pain Week 2 to 4: Meaningful improvement in nerve-related symptoms (reduced radiating pain, improved sensation) Week 4 to 6: Continued structural healing, further functional improvement Post-protocol: Maximum benefits from a single course typically manifest by week 8 to 12 as tissue remodeling continues Use the SeekPeptides peptide calculator to determine exact dosing based on your vial concentration and desired dose
Clinical services themselves - consultations and medical reviews - are non-refundable once rendered
US$ 27.41
US$ 20.22
US$ 29.66
